After tumor recurrence, we administered standardized chemotherapy, and currently, the patient’s testosterone and tumor markers (such as CA125, human epididymis protein 4, CA153, CA199, CEA, AFP) are all normal, with imaging examinations also showing no tumor recurrence. This evidence concerns the gene WFDC2 and neoplasm.